1. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
2. Government of Canada . National Advisory Committee on Immunization (NACI): guidance on the prioritization of initial doses of COVID-19 vaccine(s). [Internet. Accessed April 27, 2021.] Available from: www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunizationnaci/guidance-prioritization-initial-doses-covid-19-vaccines.html
3. Centers for Disease Control and Prevention . Advisory Committee on Immunization Practices (ACIP). Recommendation for allocation of COVID-19 vaccine in United States. [Internet. Accessed April 27, 2021]. Available from: www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/covid-19.html
4. GOV.UK . Joint Committee on Vaccination and Immunisation (JCVI). Public Health England. COVID-19: the green book, chapter 14a. [Internet. Accessed April 27, 2021]. Available from: www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a
5. Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial